NCT05805865

Brief Summary

Objectives: To assess the change in gingival index (GI) and plaque index (PI) when comparing the use of toothpaste tablets to conventional toothpaste. Methods: 40 participants were randomized into two groups: Colgate's toothpaste tablets (T) and Colgate's Cavity Protection toothpaste (C). Both groups utilized their assigned dentifrice for 2 weeks. A pre and post-assessment measured the GI and PI index. A questionnaire on the use of the product was distributed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2023

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2023

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 28, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 10, 2023

Completed
1.9 years until next milestone

Results Posted

Study results publicly available

February 21, 2025

Completed
Last Updated

February 21, 2025

Status Verified

February 1, 2025

Enrollment Period

20 days

First QC Date

March 28, 2023

Results QC Date

May 3, 2024

Last Update Submit

February 3, 2025

Conditions

Keywords

Gingival IndexPlaque IndexDentifriceToothpaste TabletsConsumer Satisfaction

Outcome Measures

Primary Outcomes (2)

  • Plaque Index Score at Baseline

    Plaque was scored according to the Turesky modification of the Quigley-Hein Plaque Index. Each tooth was divided into six surfaces, three facial and three lingual, as follows: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Teeth included in the scoring were: #3, 7, 12, 19, 23, 28. Plaque was disclosed and scored on each tooth surface according to the following criteria: 0: No plaque. 1. Separate flecks of plaque at the cervical margin. 2. A thin, continuous band of plaque (up to 1 mm) at the cer- vical margin. 3. A band of plaque wider than 1 mm but covering less than 1/3 of the side of the crown of the tooth. 4. Plaque covering at least 1/3, but less than 2/3 of the side of the crown of the tooth. 5. Plaque covering 2/3 or more of the side of the crown of the tooth. Subject-wise scores were determined by averaging the values obtained over all scorable surfaces in the mouth.

    Change between baseline at visit 1 and visit 2, two weeks post baseline.

  • Gingival Index Score at Baseline

    Gingivitis was scored according to the Löe-Silness Gingival Index. Each tooth was divided into six surfaces, three facial and three lingual, as follows: 1) mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesio-lingual; 5) mid-lingual; and 6) disto-lingual. Teeth included in the scoring were: #3, 7, 12, 19, 23, 28. The gingiva adjacent to each tooth surface was scored as follows: 0 = Absence of inflammation. 1. = Mild inflammation-slight change in color and little change in texture. 2. = Moderate inflammation-moderate glazing, redness, edema, and hypertrophy. 3. = Severe inflammation-marked redness and hypertrophy. Tendency for spontaneous bleeding. Subject-wise scores were determined by averaging the values obtained over all scorable surfaces in the mouth.

    Change between baseline at visit 1 and visit 2, two weeks post baseline.

Secondary Outcomes (1)

  • Subject Perception of Product Use

    Visit 2 two weeks post study enrollment

Study Arms (2)

Toothpaste Tablet

EXPERIMENTAL

Subjects are instructed to use one toothpaste tablet for brushing. Brushing is recommended twice daily for two minutes.

Drug: Toothpaste Tablet

Conventional Toothpaste

ACTIVE COMPARATOR

Subjects are instructed to use the toothpaste for brushing. Brushing is recommended twice daily for two minutes.

Drug: Conventional Toothpaste

Interventions

Colgate Anywhere Toothpaste Tablets

Toothpaste Tablet

Colgate Cavity Protection

Conventional Toothpaste

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects are 18 years or older;
  • Subjects who will comply with study protocol;
  • Subjects who can read and understand the consent form;
  • Subjects available during the study period;
  • Subjects have more than 20 teeth.

You may not qualify if:

  • Subjects who are pregnant and/or nursing;
  • Subjects under the age of 18.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Loma Linda University

Loma Linda, California, 92350, United States

Location

MeSH Terms

Conditions

GingivitisConsumer Behavior

Interventions

Toothpastes

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesBehavior

Intervention Hierarchy (Ancestors)

DentifricesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
Professor, Director of Student Research
Organization
Loma Linda University Health

Study Officials

  • So Ran Kwon, DDS, MS, PhD

    Loma Linda University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Investigator blinded to group
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 28, 2023

First Posted

April 10, 2023

Study Start

January 3, 2023

Primary Completion

January 23, 2023

Study Completion

January 23, 2023

Last Updated

February 21, 2025

Results First Posted

February 21, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations